Physician profile
Michael Abendroth
NPI 1750743498
$7,037.67
in general payments reported to CMS, 2019-2025
13 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $269 · 2021: $379 · 2022: $2,629 · 2023: $1,408 · 2024: $816 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,412.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,344.12 | 2019-2025 | Clareon, Hydrus Microstent, Wavelight Plus |
| Glaukos Corporation | $1,086.21 | 2020-2023 | Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Abbvie INC. | $1,058.97 | 2022-2025 | Xen Glaucoma Treatment System |
| New World Medical,INC. | $390.35 | 2022-2024 | Streamline, Kahook Dual Blade, Clearpath |
| Sight Sciences, INC. | $321.50 | 2021-2024 | Omni Surgical System |
| Alexion Pharmaceuticals, INC. | $231.93 | 2019 | |
| Rxsight INC | $192.92 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $169.74 | 2024-2025 | Envista Mx60 Iol, Stellaris, Envista Aspire Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.63 | 2021 | |
| Allergan, INC. | $54.83 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $46.80 | 2022-2025 | Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $35.83 | 2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Abendroth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.